151 John Street
Barrie, ON L4N 2L1
Canada
705-719-7425
https://www.medipharmlabs.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 166
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. David A. Pidduck | CEO & Director | 464.84k | N/A | N/A |
Mr. Keith Strachan | Co-Founder & President | 435.13k | N/A | N/A |
Mr. Greg Hunter | Chief Financial Officer | 531.64k | N/A | N/A |
Mr. Patrick McCutcheon | Founder | 581.18k | N/A | N/A |
Mr. Saravan Subramaniam | Vice President of Operations & Supply Chain | N/A | N/A | N/A |
Mr. Geoffrey Marr | Executive VP & General Counsel | N/A | N/A | N/A |
Mr. Brett Moon | Vice President of Sales | N/A | N/A | N/A |
Mr. Kirk Binns | Executive Vice President of Global Accounts | N/A | N/A | N/A |
MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
MediPharm Labs Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.